Brenda Shanahan

Mrs Shanahan joined CLINUVEL in 2007 and was Non-Executive Chair of the Board from late 2007 until July 2010. Her depth of experience across global markets and medical research provides significant value to the current Board and Company.

Mrs Shanahan is an established member of the Australian finance community with more than two decades working and investing in medical R&D and commercialisation. Previously, Mrs Shanahan was a member of the Australian Stock Exchange, an executive director of a stockbroking firm, a fund management company and an actuarial company, and chair of the St Vincent’s Medical Research Institute. She was also Chair of Challenger Listed Investments Ltd, the reporting entity for four ASX listed firms (CKT, CIF, CDI and CWT) and a non-executive director of Challenger Limited (ASX: CGF).